TARGET THERAPEUTICS INC (CIK: 0000882238) EDGAR, Information, Filings... CompaniesBIO.Com

TARGET THERAPEUTICS INC

Mailing address
47201 LAKEVIEW BLVD, FREMONT, Delaware, 94538
Phone
5104407700
State location
California
State of incorporation
Delaware
Fiscal year end
March 31
SIC
3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Filings
N/A

TARGET THERAPEUTICS INC (CIK: 0000882238) is an American company incorporated in the state of California. Head office is located at 47201 LAKEWIEW BLVD, FREMONT, California, 94538. Work in the industry 3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUS. TARGET THERAPEUTICS INC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TARGET THERAPEUTICS INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000929638-03-000032 ( Act) Size: 9 KB	Feb-14-2003
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000929638-01-500008 ( Act) Size: 10 KB	Feb-14-2001
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000929638-00-000033 ( Act) Size: 9 KB	Feb-14-2000
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000910647-98-000038 ( Act) Size: 8 KB	Feb-13-1998
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000910647-98-000035 ( Act) Size: 9 KB	Feb-13-1998
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000912057-98-000561 ( Act) Size: 27 KB	Feb-12-1998	005-43342 98533676
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000728757-98-000019 ( Act) Size: 29 KB	Jan-30-1998	005-43342 98518744
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000891618-97-001665 ( Act) Size: 4 KB	Apr-09-1997	000-19801 97577049
8-A12G/A	Document	Amendment to Form for registration of a class of securities pursuant to section 12(g) Acc-no: 0000891618-97-001584 ( Act) Size: 23 KB	Apr-02-1997	000-19801 97573620
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000943152-97-000237 ( Act) Size: 10 KB	Mar-12-1997	005-43342 97555056
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000943152-97-000236 ( Act) Size: 10 KB	Mar-12-1997	005-43342 97555055
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0000891618-97-001119 ( Act) Size: 7 KB	Mar-11-1997	333-19349 97554615
DEFM14A	Document	Definitive proxy statement relating to a merger,acquisition, or disposition Acc-no: 0000950135-97-001048 ( Act) Size: 523 KB	Mar-04-1997	000-19801 97550159
8-K	Document	Current report filing Acc-no: 0000891618-97-000912 ( Act) Size: 7 KB	Feb-25-1997	000-19801 97543346
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000864047-97-000127 ( Act) Size: 20 KB	Feb-14-1997	005-43342 97533373
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000891618-97-000500 ( Act) Size: 13 KB	Feb-13-1997	005-43342 97530021
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000812295-97-000179 ( Act) Size: 11 KB	Feb-13-1997	005-43342 97529495
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000812295-97-000165 ( Act) Size: 11 KB	Feb-13-1997	005-43342 97529407
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000891618-97-000361 ( Act) Size: 150 KB	Feb-10-1997	000-19801 97521289
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000912057-97-003155 ( Act) Size: 22 KB	Feb-05-1997	005-43342 97518351

Recent 20 filings. View all TARGET THERAPEUTICS INC filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

TARGET THERAPEUTICS INC overview
TARGET THERAPEUTICS INC job
TARGET THERAPEUTICS INC stock
TARGET THERAPEUTICS INC ownership
TARGET THERAPEUTICS INC CEO
TARGET THERAPEUTICS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.